BAY 2965501   Click here for help

GtoPdb Ligand ID: 12625

Synonyms: BAY-2965501 | BAY2965501
Compound class: Synthetic organic
Comment: BAY 2965501 is a potential first-in-class inhibitor of the atypical protein kinase C isoform protein kinase C zeta (PKCζ). It was developed for anti-tumour potential. The chemical structure was disclosed during the 'First Disclosures of New Drug Candidates' session at the April 2023 (Orlando) meeting of the AACR.
2D Structure
Click here for help

2D Structure

An image of the ligand's 2D structure. For small molecules with SMILES these are drawn using the NCI/CADD Chemical Identifier Resolver. Click on the image to access the chemical structure search tool with the ligand pre-loaded in the structure editor. For other types of ligands, e.g. longer nucleotides and peptides, a manually drawn representation of the molecule may be provided.

✖
Click here for structure editor
Physico-chemical Properties
Click here for help

Physico-chemical Properties

Calculated molecular properties are available for small molecules and natural products (not peptides). Properties were generated using the CDK toolkit. All properties were selected to enable the prediction of the Lipinski Rule-of-Five profile or ‘druglikeness’ for each ligand. For more info on each category see the help pages.

✖
Hydrogen bond acceptors 7
Hydrogen bond donors 2
Rotatable bonds 7
Topological polar surface area 136.31
Molecular weight 414.46
XLogP 1.01
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help

SMILES / InChI / InChIKey

SMILES (Simplified Molecular Input Line Entry Specification) A specification for unambiguously describing the structure of chemical molecules using short ASCII strings. Canonical SMILES specify a unique representation of the 2D structure without chiral or isotopic specifications. Isomeric SMILES include chiral specification and isotopes.

Standard InChI (IUPAC International Chemical Identifier) and InChIKey InChI is a non-proprietary, standard, textual identifier for chemical substances designed to facilitate linking of information and database searching. An InChIKey is a simplified version of a full InChI, designed for easier web searching.

✖
Canonical SMILES C[C@H](C(=O)N)N(C1=CC=C(C=C1)F)C2=NC(=C(C(=O)C3=CC=C(C=C3)OC)S2)N
Isomeric SMILES COC1=CC=C(C=C1)C(=O)C2=C(N)N=C(S2)N([C@H](C)C(N)=O)C3=CC=C(F)C=C3
InChI InChI=1S/C20H19FN4O3S/c1-11(19(23)27)25(14-7-5-13(21)6-8-14)20-24-18(22)17(29-20)16(26)12-3-9-15(28-2)10-4-12/h3-11H,22H2,1-2H3,(H2,23,27)/t11-/m1/s1
InChI Key HSBUVKDEUUJREZ-LLVKDONJSA-N
No information available.
Summary of Clinical Use Click here for help
BAY 2965501 has progressed to early stage clinical evaluation.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT05614102 A First-in-human Study to Learn How Safe the Study Treatment BAY2965501 is, to Find the Best Dose, How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, and How it Acts on Different Tumors in Participants With Advanced Solid Tumors Phase 1 Interventional Bayer